Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Aristolochic acid-associated urothelial cancer in Taiwan.

Chen CH, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu XR, Pu YS, Grollman AP.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6. doi: 10.1073/pnas.1119920109. Epub 2012 Apr 9.

PMID:
22493262
2.

Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.

Hollstein M, Moriya M, Grollman AP, Olivier M.

Mutat Res. 2013 Jul-Sep;753(1):41-9. doi: 10.1016/j.mrrev.2013.02.003. Epub 2013 Feb 17. Review.

PMID:
23422071
3.

Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.

Grollman AP.

Environ Mol Mutagen. 2013 Jan;54(1):1-7. doi: 10.1002/em.21756. Epub 2012 Dec 13. Review.

PMID:
23238808
4.

p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Slade N, Moll UM, Brdar B, Zorić A, Jelaković B.

Mutat Res. 2009 Apr 26;663(1-2):1-6. doi: 10.1016/j.mrfmmm.2009.01.005. Epub 2009 Feb 4. Review.

PMID:
19428366
5.

Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.

Arlt VM, Stiborova M, Schmeiser HH.

Mutagenesis. 2002 Jul;17(4):265-77. Review.

PMID:
12110620
6.

[Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility].

Colin P, Koenig P, Ballereau C, Phé V, Berthon N, Villers A, Biserte J, Rouprêt M.

Prog Urol. 2010 Jan;20(1):1-10. doi: 10.1016/j.purol.2009.10.010. Epub 2009 Nov 28. Review. French.

PMID:
20123521
7.

Aristolochic acid nephropathy: a worldwide problem.

Debelle FD, Vanherweghem JL, Nortier JL.

Kidney Int. 2008 Jul;74(2):158-69. doi: 10.1038/ki.2008.129. Epub 2008 Apr 16. Review.

PMID:
18418355
8.

Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.

Yang HY, Chen PC, Wang JD.

Biomed Res Int. 2014;2014:569325. doi: 10.1155/2014/569325. Epub 2014 Aug 27. Review.

PMID:
25431765
9.

Mutational signature of aristolochic acid: Clue to the recognition of a global disease.

Rosenquist TA, Grollman AP.

DNA Repair (Amst). 2016 Aug;44:205-211. doi: 10.1016/j.dnarep.2016.05.027. Epub 2016 May 20. Review.

PMID:
27237586
10.

The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.

Stiborova M, Frei E, Arlt VM, Schmeiser HH.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):5-11. Review.

PMID:
19365519
11.

Risk assessment of upper tract urothelial carcinoma related to aristolochic acid.

Wu F, Wang T.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):812-20. doi: 10.1158/1055-9965.EPI-12-1386. Epub 2013 Mar 5. Review.

PMID:
23462915
12.

[Aristolochic acid nephropathy].

Witkowicz J.

Przegl Lek. 2009;66(5):253-6. Review. Polish.

PMID:
19739583
13.

Chemical and molecular basis of the carcinogenicity of Aristolochia plants.

Schmeiser HH, Stiborovà M, Arlt VM.

Curr Opin Drug Discov Devel. 2009 Jan;12(1):141-8. Review.

PMID:
19152223
14.

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.

Stiborová M, Arlt VM, Schmeiser HH.

Int J Mol Sci. 2017 Oct 14;18(10). pii: E2144. doi: 10.3390/ijms18102144. Review.

PMID:
29036902
15.

Endemic (Balkan) nephropathy is aristolochic acid nephropathy.

Karanović S, Tomić K, Dittrich D, Borovečki F, Zavadil J, Vuković-Lela I, Karlović K, Knežević M, Jelaković B.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):43-6. Review.

PMID:
24798595
16.

Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Cosyns JP.

Drug Saf. 2003;26(1):33-48. Review.

PMID:
12495362
18.

Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.

Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH.

Carcinogenesis. 2007 Nov;28(11):2253-61. Epub 2007 Apr 13. Review.

PMID:
17434925
19.

Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.

Kucab JE, Phillips DH, Arlt VM.

FEBS J. 2010 Jun;277(12):2567-83. doi: 10.1111/j.1742-464X.2010.07676.x. Review.

PMID:
20553493
20.

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Jadot I, Declèves AE, Nortier J, Caron N.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E297. doi: 10.3390/ijms18020297. Review.

PMID:
28146082

Supplemental Content

Support Center